Top Biotechnology & Medical Research stocks in United States
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
CRBUCaribou Biosciences | $148.12m | n/a | n/a |
ELEVElevation Oncology | $147.52m | n/a | n/a |
ABOSAcumen Pharmaceuticals | $145.39m | n/a | n/a |
RIGLRigel Pharmaceuticals | $144.33m | n/a | n/a |
ADVMAdverum Biotechnologies | $142.39m | n/a | n/a |
PIIIP3 Health Partners | $142.35m | n/a | n/a |
CRVOCervoMed | $141.30m | 8.67 | n/a |
GALTGalectin Therapeutics | $140.45m | n/a | n/a |
RPTXRepare Therapeutics | $140.07m | n/a | n/a |
PRQRProQR Therapeutics NV | $139.85m | n/a | n/a |
CYDYCytodyn | $138.08m | n/a | n/a |
SYRSSyros Pharmaceuticals | $137.92m | n/a | n/a |
CMPXCompass Therapeutics. | $137.59m | n/a | n/a |
ADAGAdagene | $135.04m | n/a | n/a |
PRDSPardes Biosciences | $133.95m | n/a | n/a |
IVVDInvivyd | $131.25m | n/a | n/a |
NGMNGM Biopharmaceuticals | $128.53m | n/a | n/a |
KNTEKinnate Biopharma | $125.62m | n/a | n/a |
KODKodiak Sciences | $123.46m | n/a | n/a |
DBTXDecibel Therapeutics | $123.37m | n/a | n/a |